All In MedTech

Device Trial Radar · NCT01610622

Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique

Last checked: Nov 20, 2026Latest source record: May 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

7

Actual

Start

Mar 2012

Primary completion

May 2013

Study completion May 2013

Sponsor

Lead sponsor
Transonic Systems Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Jun 4, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, up to 1 month
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Presently there is no apparatus, clinically available, for routine determination of cardiac output (CO) in children. The goal of this research is to develop new technology that will help determine CO in neonates.

Conditions

  • Neonatal Intensive Care

Interventions

  • COstatus cardiac output measurement with isotonic salineDevice

    Isotonic saline, which is the indicator, is injected to obtain COstatus cardiac output measurements. No other interventions are made for the purpose of the study.

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Crouse Hospital

    Syracuse, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.